John Dixon

DePuy Orthopaedics, Inc. engages in the design, manufacture, and distribution of orthopedic devices and supplies. Its products are used primarily by orthopedic medical specialists and spinal neurosurgeons in both surgical and non-surgical therapy. The company was founded on December 13, 2016 and is headquartered in Warsaw, IN.

Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.

Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland.

Detica Ireland Ltd. provides enterprise financial crime and compliance software to the financial services. The company was founded in 1998 and is headquartered in Dublin, Ireland.

Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

Tedcastle Holdings Ltd. operating as a holding company with interest in distribution and importing of oil. The company is headquartered in Dublin, Ireland.

TVC Holdings Plc - Private Equity (TVC) is an unquoted investment firm based in Dublin, Ireland.

ArjoHuntleigh AB manufactures and sells medical devices and solutions for mobility, lifting, and wound care. Its products include floor and ceiling lifters; slings; medical and therapeutic beds; disinfectors; and VTE prevention devices. The company is headquartered in Malmö, Sweden.

Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX.

Vitanova Biomedical, Inc. is a biotechnology company based in the United States that focuses on improving the lives of cancer patients and healthcare professionals. The private company is based in Kerrville, TX. The company aims to achieve this through the development and commercialization of their novel light-activated intracellular acidosis platform cancer therapy. Vitanova Biomedical is currently working on preclinical evidence to support progress towards regulatory clearance and market commercialization. The company was founded by Matt Gdovin and Greg Espenhover. Tom Roberts has been the CEO of the company since 2016.

Quantum Diamond Technologies, Inc. develops and commercializes nanoscale devices. The company is headquartered in Somerville, MA.

Cognifisense, Inc. is a technology company based in Sunnyvale, CA. Cognifisense's core product is virtual reality neuropsychological therapy (VRNT), which is a patented virtual reality-based therapy designed to treat chronic pain. The therapy combines psychological therapies with the immersive power of VR to address the maladaptive neuroplastic changes in the brain that drive chronic pain. The company was founded by Tassilo Baeuerle and Harald F. Stock, with Tassilo Baeuerle serving as CEO since incorporation.

Domus Diagnostics, Inc. is a company that aims to create affordable, user-friendly, accurate, and rapid tests for infectious diseases to address the needs raised by current and future public health crises. Domus Diagnostics seeks to change how infectious disease testing is done worldwide, with the goal of providing home testing for everyone, everywhere, to prevent future pandemics. The company was founded by John Reif, Harald F. Stock, and Xin Song, and is co-located in Durham and Park City, UT, with a product testing lab at the Research Triangle Park in North Carolina.